Skip to Content
Merck
  • Fingerprinting of psychoactive drugs in zebrafish anxiety-like behaviors.

Fingerprinting of psychoactive drugs in zebrafish anxiety-like behaviors.

PloS one (2014-08-01)
Caio Maximino, Annanda Waneza Batista da Silva, Juliana Araújo, Monica Gomes Lima, Vanessa Miranda, Bruna Puty, Rancés Benzecry, Domingos Luiz Wanderley Picanço-Diniz, Amauri Gouveia, Karen Renata Matos Oliveira, Anderson Manoel Herculano
ABSTRACT

A major hindrance for the development of psychiatric drugs is the prediction of how treatments can alter complex behaviors in assays which have good throughput and physiological complexity. Here we report the development of a medium-throughput screen for drugs which alter anxiety-like behavior in adult zebrafish. The observed phenotypes were clustered according to shared behavioral effects. This barcoding procedure revealed conserved functions of anxiolytic, anxiogenic and psychomotor stimulating drugs and predicted effects of poorly characterized compounds on anxiety. Moreover, anxiolytic drugs all decreased, while anxiogenic drugs increased, serotonin turnover. These results underscore the power of behavioral profiling in adult zebrafish as an approach which combines throughput and physiological complexity in the pharmacological dissection of complex behaviors.

MATERIALS
Product Number
Brand
Product Description

Diazepam for system suitability, European Pharmacopoeia (EP) Reference Standard
Supelco
Sodium Nitroprusside, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
N-Methyl-D-aspartic acid, ≥98% (TLC), solid
Sigma-Aldrich
Diazepam
Diazepam, European Pharmacopoeia (EP) Reference Standard
Supelco
Diazepam solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®